FDA seeks more safety data on Antares testosterone drug
January 13, 2015 at 07:31 AM EST
Jan 13 (Reuters) - Antares Pharma Inc said the U.S. Food and Drug Administration has asked for additional safety data on its testosterone drug after a patient developed hives in a mid-stage trial.
